Literature DB >> 16723649

Toll-like receptors, NOD1, and NOD2 in oral epithelial cells.

Y Sugawara1, A Uehara, Y Fujimoto, S Kusumoto, K Fukase, K Shibata, S Sugawara, T Sasano, H Takada.   

Abstract

Oral epithelium might be the first barrier against oral bacteria in periodontal tissue. We hypothesized that oral epithelium is endowed with innate immune receptors for bacterial components, which play roles in host defense against bacterial infection without being accompanied by excessive inflammatory responses. We found clear expression of Toll-like receptor (TLR)4 as well as TLR2, and strong expression of NOD1 and NOD2 in normal oral epithelial tissues by immunohistochemical analysis. We also showed that primary oral epithelial cells in culture expressed these molecules using PCR, flow cytometry, and immunostaining. In inflamed oral epithelium, cell-surface localizations of TLR2 and TLR4 were more clearly observed than in healthy tissue. Upon stimulation with synthetic ligands for these receptors, the expression of beta-defensin 2 was markedly up-regulated. These findings indicate that these molecules in oral epithelial cells are functional receptors that induce antibacterial responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16723649     DOI: 10.1177/154405910608500609

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  55 in total

Review 1.  Epithelial cells and innate antifungal defense.

Authors:  G Weindl; J Wagener; M Schaller
Journal:  J Dent Res       Date:  2010-04-15       Impact factor: 6.116

Review 2.  Periodontitis: a polymicrobial disruption of host homeostasis.

Authors:  Richard P Darveau
Journal:  Nat Rev Microbiol       Date:  2010-07       Impact factor: 60.633

3.  GAS6 is a key homeostatic immunological regulator of host-commensal interactions in the oral mucosa.

Authors:  Maria Nassar; Yaara Tabib; Tal Capucha; Gabriel Mizraji; Tsipora Nir; Meirav Pevsner-Fischer; Gili Zilberman-Schapira; Oded Heyman; Gabriel Nussbaum; Herve Bercovier; Asaf Wilensky; Eran Elinav; Tal Burstyn-Cohen; Avi-Hai Hovav
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-03       Impact factor: 11.205

4.  Modulation of expression of innate immunity markers CXCL5/ENA-78 and CCL20/MIP3alpha by protease-activated receptors (PARs) in human gingival epithelial cells.

Authors:  Maryam G Rohani; Richard P Beyer; Beth M Hacker; Henrik Dommisch; Beverly A Dale; Whasun O Chung
Journal:  Innate Immun       Date:  2009-06-30       Impact factor: 2.680

5.  Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling.

Authors:  Günther Weindl; Julian R Naglik; Susanne Kaesler; Tilo Biedermann; Bernhard Hube; Hans Christian Korting; Martin Schaller
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

6.  Pivotal role of NOD2 in inflammatory processes affecting atherosclerosis and periodontal bone loss.

Authors:  Huaiping Yuan; Sami Zelkha; Sami Zelka; Marina Burkatovskaya; Rohit Gupte; Susan E Leeman; Salomon Amar
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

7.  Analysis of Expression and Localization of TLR-2 by Immunofluorescent Technique in Healthy and Inflammed Oral Tissues.

Authors:  Romaldin S D'Souza; Kishore G Bhat; D Sailaja; Deepa V Babji; Tushar K Bandiwadekar; Ramanand M Katgalkar
Journal:  J Clin Diagn Res       Date:  2013-12-15

8.  Treponema denticola does not induce production of common innate immune mediators from primary gingival epithelial cells.

Authors:  C A Brissette; T-T T Pham; S R Coats; R P Darveau; S A Lukehart
Journal:  Oral Microbiol Immunol       Date:  2008-12

Review 9.  Bacterial invasion of epithelial cells and spreading in periodontal tissue.

Authors:  Gena D Tribble; Richard J Lamont
Journal:  Periodontol 2000       Date:  2010-02       Impact factor: 7.589

Review 10.  The potential of p38 MAPK inhibitors to modulate periodontal infections.

Authors:  Keith L Kirkwood; Carlos Rossa
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.